Editors' ChoiceCORONAVIRUS

An ACE therapy for COVID-19

See allHide authors and affiliations

Science Translational Medicine  29 Apr 2020:
Vol. 12, Issue 541, eabb5676
DOI: 10.1126/scitranslmed.abb5676

Abstract

Recombinant human soluble ACE2 inhibits SARS-CoV-2 viral infection in human organoids in vitro.

View Full Text

Stay Connected to Science Translational Medicine